Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEOPLE: Post-Exposure Prophylaxis for Leprosy
NCT03662022Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of rifampicin in leprosy (HD), sponsored by Institute of Tropical Medicine Antwerp. Started Jan 2019; status: completed.
02
Drugs
rifampicin
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT03662022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662022.